As shown in Table 1, CKD patients had significantly lower concentrations of TGF-β1 and TGF-β3 compared to the controls (p<0.001), while there was no difference in the concentration of TGF-β2 between CKD patients and controls (p=0.062). This evidence concerns the gene TGFB2 and chronic kidney disease.